HTF MI recently introduced latest version Global Nicotinamide Mononucleotide (NMN) Market Study 2019. It covered product Scope, Market Share, Size, Revenue, Opportunities, Growth Rate, Sales Growth, Demand, Supply, Production*, Capacity*. The study is segmented by region, type and application and market data is provided for historical and forecast years.
The growth of the Nicotinamide Mononucleotide (NMN) market has been attributed to demand in application/end-users such as Dietary Supplements, Pharmaceutical, Food & Beverages & Others. Furthermore the research is geographically segmented as North America, Europe, Asia-Pacific etc.
What is NMN (β-nicotinamide mononucleotide)?
NMN (β-nicotinamide mononucleotide) is a substance included in the vitamin B3 group, and it is present in all organisms. It is enzyme-based and it can be found in foods such as broccoli and edamame beans, but we cannot replenish our NMN body stock by simple oral ingest. NMN is produced in the body, and it is a coenzyme essential to sustain life.
NMN is converted to NAD+ and acts on the life support center of the hypothalamus, which in turn acts on skeletal muscle, viscera, cells, mitochondria, blood vessels, nerves and response proteins (signal substances) among others, all essential for sustaining life.
NMN is a precursor of NAD+. That means it is transformed into NAD+, but even if we ingest NAD+ directly, we cannot obtain the same effects as with NMN. In fact, when NAD+ is ingested, most of it is broken up in the digestive tract.
In addition, in order to understand the mechanisms of action of NMN, the non-profit organization The Systems Biology Institute (SBI) (representative: Hiroaki Kitano) has carried out a study called Understanding the Intracellular Mechanism of NMN by Multi-Omics Analysis.